Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ro 27-2441 in moderate persistent asthma
NCT00048022Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2002
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Ro 27-2771 in asthma, sponsored by Roche. Started Oct 2002; status: completed.
02
Drugs
Ro 27-2771
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00048022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048022.